BAJAJ BROKING

Notification
Divine Hira Jewellers IPO is Open!
Apply for the Divine Hira Jewellers IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
sequent scientific ltd. stock

Sequent Scientific Ltd. Share Price

144.56 5.38 (3.86%)
Mar 19 2025 03:30 PM Pharmaceuticals NSE: SEQUENT

Sequent Scientific Ltd. Share Price Update

As of the latest trading session, Sequent Scientific Ltd. share price is currently at 144.56, which is up by 5.38 from its previous closing. Today, the stock has fluctuated between 140.05 and 146.49. Over the past year, Sequent Scientific Ltd. has achieved a return of 18.65 %. In the last month alone, the return has been -5.82 %. Read More...

Sequent Scientific Ltd. Performance

Day Range

Low140.05 High146.49
144.56

52 Week Range

Low 92.05 High 240.70
144.56

Sequent Scientific Ltd. Share Price

14296

512529

SEQUENT

img img img img

Open Price

140.05

Prev. Close

139.18

Volume (Shares)

693894.00

Total traded value

1003.09

Upper Circuit

153.09

Lower Circuit

125.26

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Sequent Scientific Ltd. Fundamentals


(Standalone)

Market Cap (Cr) 3605.81
PE Ratio (TTM) 228.28
Book Value / Share 44.29
Beta 1.35
ROE 0.22%
EPS (TTM) 0.74
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.81

Sequent Scientific Ltd. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 36.27
Operating Expense 44.16
Net Profit 2.81
Net Profit Margin (%) 7.74
Earnings Per Share (EPS) 0.11
EBITDA 7.09
Effective Tax Rate (%) 23.64
Particulars SEP 2024 (Values in Cr)
Revenue 41.99
Operating Expense 47.21
Net Profit 4.26
Net Profit Margin (%) 10.14
Earnings Per Share (EPS) 0.17
EBITDA 9.53
Effective Tax Rate (%) 33.54
Particulars JUN 2024 (Values in Cr)
Revenue 57.67
Operating Expense 62.46
Net Profit 4.50
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 0.18
EBITDA 8.86
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 36.77
Operating Expense 45.65
Net Profit 3.76
Net Profit Margin (%) 10.22
Earnings Per Share (EPS) 0.15
EBITDA 7.21
Effective Tax Rate (%) 8.29
Particulars DEC 2023 (Values in Cr)
Revenue 42.21
Operating Expense 49.55
Net Profit 4.58
Net Profit Margin (%) 10.85
Earnings Per Share (EPS) 0.18
EBITDA 9.29
Effective Tax Rate (%) 24.79
Particulars MAR 2024 (Values in Cr)
Revenue 168.52
Operating Expense 208.48
Net Profit 0.63
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.03
EBITDA 13.07
Effective Tax Rate (%) 373.91
Particulars MAR 2023 (Values in Cr)
Revenue 222.69
Operating Expense 260.67
Net Profit -6.08
Net Profit Margin (%) -2.73
Earnings Per Share (EPS) -0.24
EBITDA 1.87
Effective Tax Rate (%) 37.64
Particulars MAR 2022 (Values in Cr)
Revenue 219.63
Operating Expense 231.58
Net Profit 14.80
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 0.60
EBITDA 26.89
Effective Tax Rate (%) 5.67
Particulars MAR 2021 (Values in Cr)
Revenue 265.46
Operating Expense 241.97
Net Profit 32.11
Net Profit Margin (%) 12.09
Earnings Per Share (EPS) 1.30
EBITDA 52.70
Effective Tax Rate (%) 21.44
Particulars MAR 2020 (Values in Cr)
Revenue 227.33
Operating Expense 219.09
Net Profit 21.34
Net Profit Margin (%) 9.38
Earnings Per Share (EPS) 0.88
EBITDA 36.80
Effective Tax Rate (%) 6.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.32
ROE % -3.09
ROCE % 0.45
Total Debt to Total Equity 0.69
EBITDA Margin 4.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.01
ROE % -9.04
ROCE % -3.52
Total Debt to Total Equity 0.58
EBITDA Margin 1.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.50
ROE % 6.31
ROCE % 6.57
Total Debt to Total Equity 0.45
EBITDA Margin 8.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.30
ROE % 13.98
ROCE % 14.62
Total Debt to Total Equity 0.44
EBITDA Margin 15.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.66
ROE % 10.17
ROCE % 10.78
Total Debt to Total Equity 0.48
EBITDA Margin 15.30
Particulars MAR 2024 (Values in Cr)
Book Value / Share 43.59
ROE % 0.22
ROCE % 0.52
Total Debt to Total Equity 0.03
EBITDA Margin 8.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.43
ROE % -0.58
ROCE % -0.68
Total Debt to Total Equity 0.02
EBITDA Margin 0.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.55
ROE % 1.43
ROCE % 1.65
Total Debt to Total Equity 0.01
EBITDA Margin 12.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.45
ROE % 3.27
ROCE % 4.34
Total Debt to Total Equity 0.02
EBITDA Margin 19.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 35.68
ROE % 2.23
ROCE % 2.79
Total Debt to Total Equity 0.04
EBITDA Margin 16.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.83
Total Assets 1540.38
Total Liabilities 1540.38
Total Equity 712.95
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) -2.32
Return on Capital (%) -3.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 41.74
Total Assets 1529.12
Total Liabilities 1529.12
Total Equity 749.19
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -7.92
Return on Capital (%) -10.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 59.25
Total Assets 1450.97
Total Liabilities 1450.97
Total Equity 740.10
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 2.82
Return on Capital (%) 3.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.19
Total Assets 1392.55
Total Liabilities 1392.55
Total Equity 776.31
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 6.85
Return on Capital (%) 9.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 75.82
Total Assets 1462.64
Total Liabilities 1462.64
Total Equity 731.84
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 4.77
Return on Capital (%) 6.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.95
Total Assets 1187.59
Total Liabilities 1187.59
Total Equity 1087.22
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) 0.05
Return on Capital (%) 0.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 1122.77
Total Liabilities 1122.77
Total Equity 1058.36
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -0.54
Return on Capital (%) -0.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.88
Total Assets 1124.23
Total Liabilities 1124.23
Total Equity 1041.08
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 1.31
Return on Capital (%) 1.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.74
Total Assets 1102.12
Total Liabilities 1102.12
Total Equity 1029.51
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 2.91
Return on Capital (%) 3.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.71
Total Assets 997.37
Total Liabilities 997.37
Total Equity 886.21
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 2.13
Return on Capital (%) 2.33
Particulars MAR 2024 (Values in Cr)
Net Income -54.64
Cash from Operations 44.65
Cash from Investing -5.92
Cash from Financing -1.43
Net change in Cash 23.23
Free Cash Flow 75.45
Particulars MAR 2023 (Values in Cr)
Net Income -137.65
Cash from Operations 31.45
Cash from Investing -64.95
Cash from Financing 32.22
Net change in Cash -15.92
Free Cash Flow 117.63
Particulars MAR 2022 (Values in Cr)
Net Income 52.93
Cash from Operations 57.36
Cash from Investing -95.56
Cash from Financing 67.25
Net change in Cash 2.28
Free Cash Flow 89.82
Particulars MAR 2021 (Values in Cr)
Net Income 145.45
Cash from Operations 158.54
Cash from Investing 9.64
Cash from Financing -138.75
Net change in Cash -14.35
Free Cash Flow 211.37
Particulars MAR 2020 (Values in Cr)
Net Income 94.07
Cash from Operations 127.18
Cash from Investing -72.27
Cash from Financing -42.75
Net change in Cash 0.30
Free Cash Flow 167.90
Particulars MAR 2024 (Values in Cr)
Net Income -0.23
Cash from Operations -29.19
Cash from Investing 5.47
Cash from Financing 22.31
Net change in Cash 0.84
Free Cash Flow -19.66
Particulars MAR 2023 (Values in Cr)
Net Income -9.74
Cash from Operations 38.44
Cash from Investing -50.70
Cash from Financing 0.24
Net change in Cash -12.71
Free Cash Flow 47.30
Particulars MAR 2022 (Values in Cr)
Net Income 15.69
Cash from Operations 11.11
Cash from Investing -4.24
Cash from Financing 7.24
Net change in Cash 12.36
Free Cash Flow 17.56
Particulars MAR 2021 (Values in Cr)
Net Income 43.44
Cash from Operations 19.09
Cash from Investing 16.55
Cash from Financing -21.32
Net change in Cash -2.43
Free Cash Flow 28.61
Particulars MAR 2020 (Values in Cr)
Net Income 22.81
Cash from Operations 32.39
Cash from Investing -17.68
Cash from Financing -10.71
Net change in Cash 1.80
Free Cash Flow 37.78

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 138.90
  • 26 Days 149.90
  • 10 Days 142.40
  • 50 Days 158.20
  • 12 Days 143.60
  • 100 Days 165.70
  • 20 Days 147.40
  • 200 Days 161.10

Sequent Scientific Ltd. Future

Future: Price

27 Mar
3437.25
24 Apr
3457.6
25 May
01K2.1K3.2K4.3K

Discount/Premium

27 Mar
7.45
24 Apr
27.8
25 May
09182635

Active Calls (Expiry: 27 Mar 2025)

Strike

3,500
2500
3,600
1375
3,400
1355
25 May
07751.5K2.3K3.1K

Active Puts (Expiry: 27 Mar 2025)

Strike

3,400
422
3,500
376
3,300
220
25 Jul
0130260390520

Sequent Scientific Ltd. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
29.27
Promoter Holdings
52.6
FII
6.09
DII
12.01
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ca Harbor Investments Shareholding of Promoter and Promoter Group 1.31680103E8 52.61
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 2.2634443E7 9.04
Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor Public Shareholding 4078604.0 1.63

Sequent Scientific Ltd.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
07 Nov, 20238Interim07 Nov, 2023Equity shares
21 Jun, 202320Final21 Jun, 2023Equity shares
07 Nov, 20226Interim09 Nov, 2022Equity shares
21 Jun, 202218Final22 Jun, 2022Equity shares
29 Oct, 20216Interim01 Nov, 2021Equity shares
21 Jun, 202117Final23 Jun, 2021Equity shares
05 Nov, 20205Interim06 Nov, 2020Equity shares
06 Mar, 202010Interim 209 Mar, 2020Equity shares
04 Nov, 20194Interim05 Nov, 2019Equity shares
02 Jul, 20199Final04 Jul, 2019Equity shares
05 Nov, 20184Interim06 Nov, 2018Equity shares
19 Jun, 20189Final21 Jun, 2018Equity shares
06 Nov, 20173Interim07 Nov, 2017Equity shares
21 Jun, 20177Final23 Jun, 2017Equity shares
21 Jun, 20175Special23 Jun, 2017Equity shares
07 Nov, 20163Interim08 Nov, 2016Equity shares
22 Mar, 20165Interim 223 Mar, 2016Equity shares
02 Feb, 20162.5Interim03 Feb, 2016Equity shares
08 Sep, 20157Final10 Sep, 2015Equity shares
28 Jan, 20152Interim29 Jan, 2015Equity shares
08 Sep, 20146Final10 Sep, 2014Equity shares
27 Jan, 20142Interim28 Jan, 2014Equity shares
05 Sep, 20135.5Final10 Sep, 2013Equity shares
28 Jan, 20132Interim29 Jan, 2013Equity shares
06 Sep, 20124.5Final10 Sep, 2012Equity shares
31 Jan, 20121.5Interim01 Feb, 2012Equity shares
05 Sep, 20113Final07 Sep, 2011Equity shares
04 Feb, 20111.3Interim07 Feb, 2011Equity shares
03 Sep, 201013Final07 Sep, 2010Equity shares
18 Jan, 20105Interim19 Jan, 2010Equity shares
01 Sep, 200912Final03 Sep, 2009Equity shares
03 Oct, 20084.5Final07 Oct, 2008Equity shares
24 Jan, 20083.5Interim25 Jan, 2008Equity shares
01 Oct, 20075Final04 Oct, 2007Equity shares
25 Jan, 20072.5Interim29 Jan, 2007Equity shares
25 Sep, 20060Final01 Jan, 0001Equity shares
20 Sep, 20050Final22 Sep, 2005Equity shares

Learn More About Stocks

About Sequent Scientific Ltd.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Sequent Scientific Ltd.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sequent Scientific Ltd?

Answer Field

The share price of Sequent Scientific Ltd for NSE is ₹ 144.56 and for BSE is ₹ 144.6.

What is the Market Cap of Sequent Scientific Ltd?

Answer Field

The market cap of Sequent Scientific Ltd for NSE is ₹ 36,05.81 Cr. and for BSE is ₹ 36,06.80 Cr. as of now.

What is the 52 Week High and Low of Sequent Scientific Ltd?

Answer Field

The 52 Week High and Low of Sequent Scientific Ltd for NSE is ₹ 240.70 and ₹ 92.05 and for BSE is ₹ 240.90 and ₹ 91.85.

How to Buy Sequent Scientific Ltd share?

Answer Field

You can trade in Sequent Scientific Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sequent Scientific Ltd?

Answer Field

The 1 year returns on the stock has been 18.65%.

What is the Current Share Price of Sequent Scientific Ltd?

Answer Field

Sequent Scientific Ltd share price is for NSE ₹ 144.56 & for BSE ₹ 144.6 as on Mar 19 2025 03:30 PM.

What is the Market Cap of Sequent Scientific Ltd Share?

Answer Field

The market cap of Sequent Scientific Ltd for NSE ₹ 36,05.81 & for BSE ₹ 36,06.80 as on Mar 19 2025 03:30 PM.

What is the P/E Ratio of Sequent Scientific Ltd Share?

Answer Field

As on Mar 19 2025 03:30 PM the price-to-earnings (PE) ratio for Sequent Scientific Ltd share is 228.28.

What is the PB ratio of Sequent Scientific Ltd Share?

Answer Field

As on Mar 19 2025 03:30 PM, the price-to-book (PB) ratio for Sequent Scientific Ltd share is 44.29.

How to Buy Sequent Scientific Ltd Share on Bajaj Broking App?

Answer Field

To buy Sequent Scientific Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sequent Scientific Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download
9 lakh+ Users
icon-with-text
4.3+ App Rating
icon-with-text
4 Languages
icon-with-text
₹4300+ Cr MTF Book
icon-with-text
loader